NCT02864407 Vahelva Respimat Regulatory Post-marketing Surveillance in Korean Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT02853136 Influence of Fluvoxamine on the Pharmacokinetics of BI 409306 Status COMPLETED Phase PHASE1
NCT02853123 Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients Status COMPLETED Phase PHASE4
NCT02852824 Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 655130 in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02850978 Long-term Use of Spiolto Respimat in Japanese Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT02850965 Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02848833 JARDIANCE Regulartory Post Marketing Surveillance in Korean Type 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT02845752 The Effect of STIOLTO™ RESPIMAT® on Fatigue in Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE4
NCT02839746 Treatment Convenience in Patients Treated With Dabigatran for Stroke Prophylaxis in Atrial Fibrillation (SPAF) Status COMPLETED Phase N/A
NCT02838108 The Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD Cohort Status TERMINATED Phase N/A
NCT02835833 Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02832037 Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia Status COMPLETED Phase PHASE2
NCT02821910 Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Linagliptin/Metformin Extended Release Compared With Single Tablets Status COMPLETED Phase PHASE1